Related Experiment Video

Updated: Jul 5, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Role of Stat3 in suppressing anti-tumor immunity

Marcin Kortylewski1, Hua Yu

  • 1Beckman Research Institute at City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA 91010, USA. mkortylewski@coh.org

Current Opinion in Immunology
|May 16, 2008
PubMed

Insights

Signal transducer and activator of transcription 3 (Stat3) activation in cancer promotes tumor growth and immune evasion. This pathway allows cancer cells and immune cells to partner, aiding tumor progression and therapy resistance.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cancer cells utilize survival and proliferation pathways that can also suppress the immune system.
  • Signal transducer and activator of transcription 3 (Stat3) is a key convergence point for oncogenic signaling pathways, constitutively active in many human cancers.

Purpose of the Study:

  • To elucidate the role of Signal transducer and activator of transcription 3 (Stat3) in cancer progression and immune evasion.
  • To understand how Stat3 activation in cancer cells influences the tumor microenvironment and immune response.

Main Methods:

  • Analysis of oncogenic signaling pathways.
  • Investigation of gene expression profiles related to Stat3 activation.
  • Assessment of immune suppressive factors and immunostimulatory molecules in the tumor microenvironment.

Main Results:

  • Constitutively activated Stat3 upregulates genes essential for tumor survival, proliferation, angiogenesis, and metastasis.
  • Activated Stat3 promotes the expression of immune suppressive factors.
  • Activated Stat3 inhibits the expression of Th1 immunostimulatory molecules, thereby dampening anti-tumor immunity.

Conclusions:

  • Stat3 activation is crucial for tumor immune evasion and progression.
  • The Stat3 pathway facilitates a partnership between malignant and immune cells, promoting tumor growth and therapeutic resistance.
  • Targeting Stat3 may offer a strategy to overcome immune evasion and enhance anti-cancer therapies.

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...